Conference Coverage

VIDEO: IBD epidemiology provides clues into disease underpinnings


 

AT THE 13TH WORLD CONGRESS OF GASTROENTEROLOGY

– The incidence of Crohn’s disease and ulcerative colitis has stabilized in the Western world, but is rising rapidly in newly industrialized countries, according to a systematic review of population-based studies.

The findings could provide important new insights into the environmental, genetic, and microbiome-related factors and interactions that form the underpinnings of IBD, Gilaad Kaplan, MD, of the University of Calgary (Alta.) said at the World Congress of Gastroenterology at ACG 2017.

In turn, that information could lead to approaches to reduce IBD incidence, he said in a video interview.

It has been known that Crohn’s disease and ulcerative colitis are “modern diseases of modern times,” but few studies have addressed the epidemiology of IBD in newly industrialized countries in Asia, Africa, and South America, he said.

“We see a pattern that as newly industrialized countries transition toward a westernized society, IBD emerges and its incidence rises, and there are many different explanations for that,” he said, noting that in part, the increase is due to improved health care infrastructure and advances in adoption of medical technology that lead to better identification of new cases.

“But probably one of the most important factors is that there are environmental exposures linked to the westernization of society that are creating this pressure that’s driving incidence of IBD up in many of the countries of the world,” he said. “I think if we do a lot more research focused on how environment influences microbiome, we might start to see things we could do that could potentially stem the tide of IBD.”

Dr. Kaplan reported having no relevant disclosures.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

Study shows childhood IBD increased cancer risk in adulthood
MDedge Internal Medicine
Leukocyte activation test–based elimination diet improves IBS symptoms
MDedge Internal Medicine
VIDEO: Trial posts null results for Helicobacter screening, eradication
MDedge Internal Medicine
Dabigatran, rivaroxaban linked to slight increase in GI bleeding risk
MDedge Internal Medicine
Consider PBC in diagnosing hepatobiliary disorders in UC patients
MDedge Internal Medicine
G. lamblia assemblage B more common in HIV-positive people
MDedge Internal Medicine
Synbiotic didn’t top placebo for gastrointestinal symptoms in HIV/AIDS
MDedge Internal Medicine
FISH and PCR aid in diagnosis of human intestinal spirochetosis
MDedge Internal Medicine
Simple rule boosted yield of molecular tests for enteric pathogens
MDedge Internal Medicine
More IBD remissions with higher induction vedolizumab levels
MDedge Internal Medicine

Related Articles